Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Feb 27, 2009

Mutations of New Gene Trigger 5% of Inherited ALS Cases

  • A collaboration of scientists led by the Northwestern University Feinberg School of Medicine has found a new gene whose mutations reportedly cause 5% of inherited cases of ALS.

    The researchers identified a missense mutation in the gene encoding fused in sarcoma (FUS) in a British kindred linked to ALS6. Earlier research by the colleagues extended the genetic knowledge of familial ALS by identifying the first and second ALS genes (SOD1 and ALSIN) in addition to identifying loci on chromosomes 9, 15, 16, and X.

    The team identified two other missense mutations in eight families as part of a survey of 197 familial ALS index cases. Postmortem analysis of three FUS mutation cases showed FUS-immunoreactive cytoplasmic inclusions and mostly lower motor neuron degeneration.

    Cellular expression studies revealed aberrant localization of mutant FUS protein. FUS is involved in the regulation of transcription and RNA splicing and transport, and it has functional homology to another ALS gene, TARDBP. This suggests that a common mechanism may underlie motor neuron degeneration.

    The article is published February 27 in Science.

Related content

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »